Abstract
Oncogene addiction is thought to occur cell autonomously. Immune effectors are implicated in the initiation and restraint of tumorigenesis, but their role in oncogene inactivation-mediated tumor regression is unclear. Here, we show that an intact immune system, specifically CD4(+) T cells, is required for the induction of cellular senescence, shutdown of angiogenesis, and chemokine expression resulting in sustained tumor regression upon inactivation of the MYC or BCR-ABL oncogenes in mouse models of T cell acute lymphoblastic lymphoma and pro-B cell leukemia, respectively. Moreover, immune effectors knocked out for thrombospondins failed to induce sustained tumor regression. Hence, CD4(+) T cells are required for the remodeling of the tumor microenvironment through the expression of chemokines, such as thrombospondins, in order to elicit oncogene addiction.
Copyright © 2010 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Animals
-
Apoptosis / physiology
-
CD4-Positive T-Lymphocytes / immunology*
-
Cell Proliferation / drug effects
-
Cellular Senescence / drug effects
-
Chemokines / genetics
-
Chemokines / metabolism
-
Cyclosporine / pharmacology
-
Fusion Proteins, bcr-abl / genetics
-
Gene Expression Regulation, Neoplastic
-
Gene Silencing
-
Immunosuppressive Agents / pharmacology
-
Leukemia, Experimental / genetics
-
Leukemia, Experimental / immunology
-
Mice
-
Mice, Transgenic
-
Neoplasms / genetics
-
Neoplasms / immunology
-
Neoplasms / pathology
-
Neovascularization, Pathologic / genetics
-
Neovascularization, Pathologic / immunology
-
Oncogenes / genetics*
-
Proto-Oncogene Proteins c-myc / genetics
-
Remission Induction
-
Thrombospondin 1 / genetics
-
Thrombospondin 1 / metabolism
-
Tumor Microenvironment / drug effects
-
Tumor Microenvironment / genetics
-
Tumor Microenvironment / immunology*
Substances
-
Chemokines
-
Immunosuppressive Agents
-
Proto-Oncogene Proteins c-myc
-
Thrombospondin 1
-
Cyclosporine
-
Fusion Proteins, bcr-abl